The infinite supply trans privacy coin by Ansem, Naval Ravikant and the Mossad is trading at $7.5b FDV
The only fully homophobic privacy chain is trading at $100m FDV
Which one is wrong?
$wOCT
There's a rabbit themed Ethereum L2 with zero users trading at $440m FDV
The only fully homomorphic privacy chain is trading at $90m FDV
Which one is wrong?
$wOCT
for octra mfers. no price talk just facts
FHE. vitalik called it cryptos holy grail. compute on data thats fully encrypted, never decrypt it once. been too slow to use for years. everybody gave up
octra got it LIVE on mainnet. HFHE. encrypted ops modeled as hypergraphs running parallel on normal CPUs. no fancy hardware. wild stuff
and they didnt stop there. FHE for the compute. bulletproofs n pedersen for balance flows. formal verification so programs literally cant misbehave. three crypto guarantees stacked in one chain. most privacy coins ship ONE and act like they cooked
So again dont sell 5$ coins for 0.08 . MATH DONT LIE MFERS $OCT
https://t.co/w63BGQBXZp
https://t.co/CaKVhO8B14
These threads explain it. And if you want more, look into VVV founders involvement with @MorpheusAIs and its connection to VVV, another slow rug (again, team FSHing another TGE while convincing the community to time lock their tokens.
.@AskVenice team has sold over $10.2M in $VVV tokens...
I've tracked all the $VVV team wallets and identified their clusters.
They received tokens 4 days prior to the launch, and insta dumped right after the launch.
And Coinbase launched it day on 1?
Wallets + Proof 🧵
Any equity market weakness is a good opp to position in 2 various obvious trades:
- Biotech being the next AI tailwind theme ($TXG $ILMN $BRKR $TWT)
- The Space-X IPO going well in the 1-2 month term (betas like $RDW $RKLB $PL $LPTH)
zcash:native was never going to be a store of value and has no material form of value accrual. Nice protocol for state approved tax optimization though.
$TXG
Biotech will get a step change more interesting as AI proliferates through workflows. 10x sells the instruments and consumables that generate the data.
NIH funding has been under pressure, but interest in AI applications on spatial data plus BIOSECURE may open up new pathways after a multi year bear market in the sector.
The stock is just now peeking above its 2022 bear market low.
Any equity market weakness is a good opp to position in 2 various obvious trades:
- Biotech being the next AI tailwind theme ($TXG $ILMN $BRKR $TWT)
- The Space-X IPO going well in the 1-2 month term (betas like $RDW $RKLB $PL $LPTH)